PGGM Investments lessened its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 9.2% during the fourth quarter, Holdings Channel reports. The fund owned 143,107 shares of the company’s stock after selling 14,501 shares during the quarter. PGGM Investments’ holdings in Colgate-Palmolive were worth $13,010,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. FMR LLC increased its stake in Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after purchasing an additional 2,674,807 shares in the last quarter. AMF Tjanstepension AB grew its stake in shares of Colgate-Palmolive by 1,088.8% in the 4th quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company’s stock valued at $233,584,000 after buying an additional 2,353,268 shares during the period. Barclays PLC increased its position in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares in the last quarter. State Street Corp raised its stake in Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the period. Finally, Raymond James Financial Inc. bought a new position in Colgate-Palmolive in the fourth quarter worth approximately $132,405,000. 80.41% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several equities research analysts have recently commented on the company. Barclays decreased their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Stifel Nicolaus decreased their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. Finally, StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $101.61.
Colgate-Palmolive Stock Down 3.6 %
CL opened at $90.71 on Thursday. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The company’s 50-day moving average price is $89.03 and its two-hundred day moving average price is $94.96. The stock has a market cap of $73.61 billion, a price-to-earnings ratio of 25.77, a PEG ratio of 4.20 and a beta of 0.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the business earned $0.87 EPS. As a group, equities analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- What Is WallStreetBets and What Stocks Are They Targeting?
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- What is the Shanghai Stock Exchange Composite Index?
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- What Investors Need to Know to Beat the Market
- Why Energy Transfer Belongs on Your Watchlist
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.